NCT01207089View on ClinicalTrials.gov

To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Administration of AZD8329

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
OverweightHealthyMale
Interventions
DRUG

AZD8329

AZD8329 Oral Solution 20mg/ml

DRUG

Placebo

Placebo AZD8329 Oral Solution

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY